Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1999
10/07/1999WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999WO1999050660A1 Use of ror receptors for screening substances useful for the treatment of atherosclerosis
10/07/1999WO1999050461A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999WO1999050396A1 Nek1-related protein kinase
10/07/1999WO1999050296A1 Treatment and prevention of vascular disease
10/07/1999WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999WO1999049887A1 Use of protease inhibitors for treating skin wounds
10/07/1999WO1999049884A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049877A2 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
10/07/1999WO1999049875A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
10/07/1999WO1999049872A1 Preventives for alcoholic gastritis
10/07/1999WO1999049860A1 Agents and methods for modulation of zinc transfer by metallothionein
10/07/1999WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999WO1999049847A1 Neuroprotective composition
10/07/1999WO1999049844A2 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
10/07/1999WO1999049835A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999WO1999049774A2 Methods for the diagnosis and treatment of lung cancer
10/07/1999WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells
10/07/1999WO1999043310A3 20-hete antagonists and agonists
10/07/1999WO1999040220A3 Method of screening therapeutic agents
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999024077A3 Compositions and methods for targeted delivery of biologically-active factors
10/07/1999DE19910856A1 Strukturiertes Wasser für eine verbesserte Anfeuchtung Structured water for improved wetting
10/07/1999DE19814963A1 MAPKAP Kinase 2-Hemmer und ihre Verwendung für die anti-inflammatorische Therapie MAPKAP kinase 2 inhibitors and their use for the anti-inflammatory therapy
10/07/1999CA2735260A1 Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2326774A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999CA2326771A1 Agents and methods for modulation of zinc transfer by metallothionein
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999CA2326438A1 Use of protease inhibitors for treating skin wounds
10/07/1999CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999CA2324652A1 Nek1-related protein kinase
10/07/1999CA2324476A1 Treatment and prevention of vascular disease
10/07/1999CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999CA2323748A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999CA2320421A1 Prophylactic drug for prevention of alcoholic gastritis
10/07/1999CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/07/1999CA2291780A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
10/07/1999CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946721A1 Human growth gene and short stature gene region
10/06/1999EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999EP0946595A2 Melanocortins
10/06/1999EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999EP0946205A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0946190A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
10/06/1999EP0946189A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
10/06/1999EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
10/06/1999EP0946183A1 Methods of treating or preventing cardiac arrhythmia
10/06/1999EP0946180A1 Method for stimulating bone formation
10/06/1999EP0946178A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/06/1999EP0946175A1 USE OF AN H+, K+ -ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS
10/06/1999EP0946172A1 Method for inhibiting stress-activated protein kinases
10/06/1999EP0946167A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/06/1999EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999EP0946165A1 Integrin antagonists
10/06/1999EP0946157A2 The topical use of kappa opioid agonists to treat ocular pain
10/06/1999EP0946155A1 Pharmaceutical composition for treating fecal incontinence and anal itch
10/06/1999EP0946151A1 Ascending-dose dosage form
10/06/1999EP0946147A1 Treatment of equine laminitis
10/06/1999EP0946146A2 New aqueous medicament preparations for the production of propellent gas-free aerosols
10/06/1999EP0946099A1 Endoparasiticidal and ectoparasiticidal agents
10/06/1999EP0866693A4 Topically applied, structural cellulite treatments
10/06/1999CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes
10/06/1999CN1230956A Method of producing polyphenol-containing compositions
10/06/1999CN1230894A Pharmaceutical composition containing a 5HT2C antagonist and A D2 antagonist
10/06/1999CN1230891A Lectin compositions and uses thereof
10/06/1999CN1230889A Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
10/06/1999CN1230886A Combination therapy for treatment of psychoses
10/06/1999CN1230875A Flavonol containing food supplements
10/06/1999CN1045392C Internal guide therapeutic medicine for rheumatoid disease and making method
10/05/1999US5962536 Injectable propofol formulations
10/05/1999US5962532 Therapeutic method with capsaicin and capsaicin analogues
10/05/1999US5962526 Pharmaceutical compositions containing hydroxycarboxylic acids and/or ketocarboxylic acids and methods of using same
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962517 Pharmaceutical compositions and methods for treating acne
10/05/1999US5962515 Immunomodulators
10/05/1999US5962514 Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist
10/05/1999US5962503 Use of cholinesterase inhibitors in the treatment of xerostomia
10/05/1999US5962473 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
10/05/1999US5962464 Side effect reduction
10/05/1999US5962444 Hormone inhibitor; hormone replacement therapy
10/05/1999US5962433 Topical composition containing hyaluronic acid and NSAIDS
10/05/1999US5962416 Somatotropin releasing compound for accelerating hoof growth in horses
10/05/1999US5962415 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
10/05/1999US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999US5962300 Polynucleotide which encodes a polypeptide tumor suppressor; for diagnosis, prevention, and treatment of cancer, eczema, psoriasis, psoriasis, scleroderma, dermatitis, skin atrophy, and other skin disorders; anticarcinogenic agents
10/05/1999US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system.
10/05/1999US5962259 Response regulator polynucleotides
10/05/1999US5962232 Protein kinase molecules
10/05/1999US5962216 Tumor-activated prodrug compounds and treatment
10/05/1999US5962017 Pharmaceutical compositions comprising cyclosporins
10/05/1999US5962014 Hydrophilic component other than the hydrophilic surfactant, lipophilic component and hydrophilic surfactant other than the hydrophilic component; upon dilution with water an oil-in-water microemulsion is formed.
10/05/1999US5961969 Enhancing natural killer cell cytotoxicity.
1 ... 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 ... 1151